139 related articles for article (PubMed ID: 15289739)
1. Prognostic impact of survivin, cyclin D1, integrin beta1, and VEGF in patients with small adenocarcinoma of stage I lung cancer.
Oshita F; Ito H; Ikehara M; Ohgane N; Hamanaka N; Nakayama H; Saito H; Yamada K; Noda K; Mitsuda A; Kameda Y
Am J Clin Oncol; 2004 Aug; 27(4):425-8. PubMed ID: 15289739
[TBL] [Abstract][Full Text] [Related]
2. Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung.
Ikehara M; Oshita F; Kameda Y; Ito H; Ohgane N; Suzuki R; Saito H; Yamada K; Noda K; Mitsuda A
Oncol Rep; 2002; 9(4):835-8. PubMed ID: 12066218
[TBL] [Abstract][Full Text] [Related]
3. Expression of cyclin D1 but not of cyclin E is an indicator of poor prognosis in small adenocarcinomas of the lung.
Ikehara M; Oshita F; Ito H; Ohgane N; Suzuki R; Saito H; Yamada K; Noda K; Mitsuda A; Kameda Y
Oncol Rep; 2003; 10(1):137-9. PubMed ID: 12469159
[TBL] [Abstract][Full Text] [Related]
4. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O
J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638
[TBL] [Abstract][Full Text] [Related]
5. High expression of integrin beta1 and p53 is a greater poor prognostic factor than clinical stage in small-cell lung cancer.
Oshita F; Kameda Y; Hamanaka N; Saito H; Yamada K; Noda K; Mitsuda A
Am J Clin Oncol; 2004 Jun; 27(3):215-9. PubMed ID: 15170136
[TBL] [Abstract][Full Text] [Related]
6. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH
Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis.
Chen P; Zhu J; Liu DY; Li HY; Xu N; Hou M
Med Oncol; 2014 Jan; 31(1):775. PubMed ID: 24338338
[TBL] [Abstract][Full Text] [Related]
8. p16 inactivation in small-sized lung adenocarcinoma: its association with poor prognosis.
Kawabuchi B; Moriyama S; Hironaka M; Fujii T; Koike M; Moriyama H; Nishimura Y; Mizuno S; Fukayama M
Int J Cancer; 1999 Feb; 84(1):49-53. PubMed ID: 9988232
[TBL] [Abstract][Full Text] [Related]
9. Survivin expression is an independent poor prognostic marker in lung adenocarcinoma but not in squamous cell carcinoma.
Sun PL; Jin Y; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
Virchows Arch; 2013 Sep; 463(3):427-36. PubMed ID: 23907568
[TBL] [Abstract][Full Text] [Related]
10. [Expression and prognostic value of survivin protein in early-stage non-small cell lung cancer].
Zhu ZH; Yang H; Fu JH; Hu Y; Ma Y; Wu QL; Rong TH; Wang DF
Ai Zheng; 2007 Nov; 26(11):1268-71. PubMed ID: 17991331
[TBL] [Abstract][Full Text] [Related]
11. [Expression and clinical significance of apoptosis-related oncogenes in stage I-II non-small cell lung cancer].
Wang DF; Zeng CG; Lin YB; Hou JH; Zhu ZH
Ai Zheng; 2006 Mar; 25(3):359-62. PubMed ID: 16536995
[TBL] [Abstract][Full Text] [Related]
12. Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma.
Lee J; Kang WK; Park JO; Park SH; Park YS; Lim HY; Kim J; Kong J; Choi MG; Sohn TS; Noh JH; Bae JM; Kim S; Lim DH; Kim KM; Park CK
APMIS; 2009 Aug; 117(8):598-606. PubMed ID: 19664131
[TBL] [Abstract][Full Text] [Related]
13. Prognostic index expression of cyclin-D1, cerbB-2 and VEGF: metastases vs corresponding primary cancers and metastatic vs non-metastatic adenocarcinomas.
Parra ER; Park JY; Saito DM; Takagaki TY; Rodrigues OR; Capelozzi VL
Histol Histopathol; 2008 Aug; 23(8):987-93. PubMed ID: 18498074
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers.
Nishio M; Koshikawa T; Yatabe Y; Kuroishi T; Suyama M; Nagatake M; Sugiura T; Ariyoshi Y; Mitsudomi T; Takahashi T
Clin Cancer Res; 1997 Jul; 3(7):1051-8. PubMed ID: 9815783
[TBL] [Abstract][Full Text] [Related]
15. Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung.
Adachi M; Taki T; Huang C; Higashiyama M; Doi O; Tsuji T; Miyake M
J Clin Oncol; 1998 Mar; 16(3):1060-7. PubMed ID: 9508191
[TBL] [Abstract][Full Text] [Related]
16. Co-existence of cyclin D1 and vascular endothelial growth factor protein expression is a poor prognostic factor for UICC stage I-III colorectal cancer patients after curative resection.
Tsai HL; Yeh YS; Chang YT; Yang IP; Lin CH; Kuo CH; Juo SH; Wang JY
J Surg Oncol; 2013 Feb; 107(2):148-54. PubMed ID: 22926658
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of integrin beta1 is a poor prognostic factor in small-cell lung cancer.
Oshita F; Kameda Y; Ikehara M; Tanaka G; Yamada K; Nomura I; Noda K; Shotsu A; Fujita A; Arai H; Ito H; Nakayama H; Mitsuda A
Anticancer Res; 2002; 22(2B):1065-70. PubMed ID: 12168902
[TBL] [Abstract][Full Text] [Related]
18. Identification of integrin β1 as a prognostic biomarker for human lung adenocarcinoma using 2D-LC-MS/MS combined with iTRAQ technology.
Zhang PF; Zeng GQ; Yi LZ; Liu JP; Wan XX; Qu JQ; Li JH; Li C; Tang CE; Hu R; Ye X; Chen Y; Chen ZC; Xiao ZQ
Oncol Rep; 2013 Jul; 30(1):341-9. PubMed ID: 23677397
[TBL] [Abstract][Full Text] [Related]
19. Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study.
Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Pilecka I; Jabłonka A
Folia Histochem Cytobiol; 2005; 43(4):237-42. PubMed ID: 16382892
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of p21waf1, cyclin D1 and retinoblastoma expression detected by immunohistochemistry in non-small cell lung cancer.
Saitoh G; Sugio K; Ishida T; Sugimachi K
Oncol Rep; 2001; 8(4):737-43. PubMed ID: 11410775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
